Accession Therapeutics is based in Oxford, UK. It has raised $53M in total funding. Latest round: Seed.
Accession Therapeutics funding overview
Accession Therapeutics is based in Oxford, UK. Accession Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in September 2021. The round record for Accession Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Primavera Venture Partners, Birk Venture, iGlobe Partners, BiomedVC, Bayern Kapital, WuXi Biologics Healthcare Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Frequently asked about Accession Therapeutics funding
How much has Accession Therapeutics raised?
Accession Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Accession Therapeutics?
Primavera Venture Partners, Birk Venture, iGlobe Partners, BiomedVC, Bayern Kapital, WuXi Biologics Healthcare Ventures are named among the investors backing Accession Therapeutics.
What was the latest Accession Therapeutics funding round?
The most recent disclosed round is a Seed, announced in September 2021.
Where is Accession Therapeutics based?
Accession Therapeutics is based in Oxford, UK.
When did Accession Therapeutics last raise?
The last disclosed Accession Therapeutics round closed in September 2021 at Seed.
Totals shown for Accession Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Oxford and the investors behind them below.
